Skip to main content
. 2022 Mar 11;13:828863. doi: 10.3389/fimmu.2022.828863

Figure 2.

Figure 2

Therapeutic efficacy after percutaneous transluminal angioplasty in patients with Takayasu arteritis and pulmonary hypertension. (A) 6 min walk distance (6-MWD). (B) N-terminal pro-brain natriuretic peptide (NT-proBNP) level. (C) Pulmonary vascular resistance (PVR); (D) Cardiac index (CI).